NDUFB6 and Alzheimer disease: According to this, a recent study demonstrated the C I specific ROS-production inhibiting effect of OP2113 (5-(4-Methoxyphenyl)-3H-1,2-dithiole-3-thione, CAS 532-11-6), and highlighted its role in therapies for Parkinson’s and Alzheimer’s diseases [25].